JAMA Pediatrics最新文献

筛选
英文 中文
School-Based Health Centers and Student Health Care Use, Need, and Health Outcomes 校本卫生中心与学生卫生保健的使用、需求和健康结果
IF 26.1 1区 医学
JAMA Pediatrics Pub Date : 2026-11-16 DOI: 10.1001/jamapediatrics.2026.5480
Ashley M. Kranz, Elizabeth C. Chase, Catria Gadwah-Meaden, Katherine M. Rancaño, Laura J. Faherty, Christine Mulhern
{"title":"School-Based Health Centers and Student Health Care Use, Need, and Health Outcomes","authors":"Ashley M. Kranz, Elizabeth C. Chase, Catria Gadwah-Meaden, Katherine M. Rancaño, Laura J. Faherty, Christine Mulhern","doi":"10.1001/jamapediatrics.2026.5480","DOIUrl":"https://doi.org/10.1001/jamapediatrics.2026.5480","url":null,"abstract":"Importance School-based health centers (SBHCs) are health clinics located in schools that provide comprehensive primary medical care at low or no cost to students. SBHCs are well positioned to improve health outcomes and health care use by eliminating transportation and cost barriers and to reduce disparities by primarily serving communities with low household incomes and high health care needs. Objective To determine the association of SBHC access with health, unmet health care need, and health care receipt for high school students in Oregon. Design, Setting, and Participants This cross-sectional study used 10 years of student survey data during 2006 to 2023 linked to information on SBHC access in high schools in Oregon. Participants were students in 11th grade statewide who took the health survey. Using entropy-balanced staggered difference-in-differences regressions, we estimated the association of having an SBHC at a student’s school with their outcomes. Data analysis was performed from July to September 2026. Exposure School-level measure of whether an SBHC was present in a high school in Oregon. Main Outcomes and Measures Three measures of mental health and suicidality, 2 measures of physical health, 2 measures of unmet health care need, and 1 measure of medical care received. Results Among 87 871 students at 180 schools, 43 397 (49.7%) were female, 42 824 (49.0%) were male, and 1157 (1.3%) were another gender. A total of 14 933 students attended a school with an SBHC during the study period. SBHC access was associated with statistically significant improvements in student mental health, with decreases in suicidal thoughts (−2.7 percentage points [pp]; 95% CI, −4.5 to −0.7 pp) and suicide attempts (−1.4 pp; 95% CI, −2.3 to −0.5 pp) and decreases in reports of unmet emotional health care needs (−2.1 pp; 95% CI, −3.8 to −0.6 pp). No other statistically significant associations with SBHC access were observed. Heterogeneous treatment effects by gender, sexual orientation, race and ethnicity, and rurality were observed. Conclusions and Relevance This study found that SBHC access was associated with improved mental health among high school students. There are nearly 4000 SBHCs in the United States, and they are primarily in schools with a high share of students from low-income families. Expanding access to SBHCs may help reduce mental health disparities.","PeriodicalId":14683,"journal":{"name":"JAMA Pediatrics","volume":"45 1","pages":""},"PeriodicalIF":26.1,"publicationDate":"2026-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149415323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cannabidiol for Severe Behavioral Problems in Youths With Intellectual Disability 大麻二酚治疗智障青少年的严重行为问题
IF 26.1 1区 医学
JAMA Pediatrics Pub Date : 2026-11-16 DOI: 10.1001/jamapediatrics.2026.5152
Daryl Efron, Kaitlyn Taylor, Jeremy L. Freeman, Noel E. Cranswick, Elizabeth J. Elliott, Jonathan M. Payne, Katherine J. Lee, Cecilia L. Moore, Lauren J. Rice, Andrew J. Davidson, Chidambaram Prakash, Cathrine Mihalopoulos, Mary Lou Chatterton, Julian N. Trollor, David R. Dossetor, Melissa Mulraney, Stewart L. Einfeld, Katrina J. Williams
{"title":"Cannabidiol for Severe Behavioral Problems in Youths With Intellectual Disability","authors":"Daryl Efron, Kaitlyn Taylor, Jeremy L. Freeman, Noel E. Cranswick, Elizabeth J. Elliott, Jonathan M. Payne, Katherine J. Lee, Cecilia L. Moore, Lauren J. Rice, Andrew J. Davidson, Chidambaram Prakash, Cathrine Mihalopoulos, Mary Lou Chatterton, Julian N. Trollor, David R. Dossetor, Melissa Mulraney, Stewart L. Einfeld, Katrina J. Williams","doi":"10.1001/jamapediatrics.2026.5152","DOIUrl":"https://doi.org/10.1001/jamapediatrics.2026.5152","url":null,"abstract":"Importance There is a high level of interest in cannabidiol (CBD) as treatment for severe behavioral problems in children with intellectual disabilities. Given the lack of evidence, clinical trials are needed to inform practice. Objective To investigate the efficacy of CBD to reduce severe behavioral problems in children and adolescents with intellectual disability. Design, Setting, and Participants This parallel design, double-blind placebo-controlled randomized clinical trial was conducted between May 11, 2021, and May 8, 2025. Participants were children and adolescents aged 6 to 18 years with an intellectual disability and severe behavioral problems from 3 children’s hospitals in Australia: The Royal Children’s Hospital in Melbourne, Monash Children’s Hospital in Melbourne, and The Children’s Hospital Westmead in Sydney. Intervention Participants were randomly assigned 1:1 to receive CBD isolate in oil (10 mg/kg/d) or placebo orally for 8 weeks, with a 4-week follow-up period. Main Outcome and Measure The primary outcome was parent-reported score on the Aberrant Behavior Checklist, Irritability (ABC-I) subscale assessed at the end of the 8-week maintenance phase. Results Of 131 participants randomized after exclusion of 1 participant randomized in error, 65 were in the CBD group and 66 were in the placebo group. Overall, mean (SD) age was 11.2 (3.1) years, and 98 participants (74.8%) were male. A total of 110 participants (84.0%) had comorbid autism. Primary outcome data were available for 61 participants in the CBD group and 63 in the placebo group. Mean (SD) ABC-I subscale scores at baseline were 32.2 (7.3) and 30.0 (6.3) in the CBD and placebo groups, respectively. Intention-to-treat analysis showed similar mean (SD) ABC-I subscale scores at the end of treatment: 21.7 (11.0) in the CBD group and 19.2 (10.7) in the placebo group (mean difference, 2.4; 95% CI, −1.5 to 6.3). A similar proportion of participants experienced at least 1 adverse event in the CBD group (41 [63.1%]) and the placebo group (40 [60.6%]). Conclusions and Relevance In this randomized clinical trial, CBD was not effective in treating severe behavioral problems in youths with intellectual disability. The results suggest that CBD should not be used to treat severe behavioral problems in this population. Trial Registration ClinicalTrials.gov Identifier: <jats:ext-link xmlns:xlink=\"http://www.w3.org/1999/xlink\" ext-link-type=\"uri\" xlink:href=\"https://clinicaltrials.gov/study/NCT04821856\">NCT04821856</jats:ext-link>","PeriodicalId":14683,"journal":{"name":"JAMA Pediatrics","volume":"93 1","pages":""},"PeriodicalIF":26.1,"publicationDate":"2026-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149415346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reduced Social Media Use and Change in Internalizing Symptoms Among High-Risk Young Adults 高危年轻人减少社交媒体使用和内化症状的改变
IF 26.1 1区 医学
JAMA Pediatrics Pub Date : 2026-11-16 DOI: 10.1001/jamapediatrics.2026.5373
Dae-Hee Han, Katherine M. Keyes, Megan A. Moreno
{"title":"Reduced Social Media Use and Change in Internalizing Symptoms Among High-Risk Young Adults","authors":"Dae-Hee Han, Katherine M. Keyes, Megan A. Moreno","doi":"10.1001/jamapediatrics.2026.5373","DOIUrl":"https://doi.org/10.1001/jamapediatrics.2026.5373","url":null,"abstract":"Importance National cohort analyses of the association between reduced social media use and subsequent improvement in internalizing problems among high-risk young adults—ie, those most likely to benefit from intervention—remain limited. Objective To assess whether reduced social media use is associated with improvements in internalizing problems among US young adults with frequent social media use and elevated internalizing problems. Design, Setting, and Participants This cohort study used data from the Population Assessment of Tobacco and Health Study (2013-2021). Repeated observations were organized into 4 consecutive, overlapping 3-wave intervals, each comprising 3 sequential survey waves ( &lt;jats:italic toggle=\"yes\"&gt;t&lt;/jats:italic&gt; , &lt;jats:italic toggle=\"yes\"&gt;t&lt;/jats:italic&gt; + 1, and &lt;jats:italic toggle=\"yes\"&gt;t&lt;/jats:italic&gt; + 2); for example, interval 1 included waves 1-3, and interval 4 included waves 4-6. Young adults aged 18 to 24 years with elevated internalizing problems (all 4 symptoms) and frequent social media use (several times a day) at wave &lt;jats:italic toggle=\"yes\"&gt;t&lt;/jats:italic&gt; were included. Data were analyzed from February to August 2026. Exposures Self-reported social media use frequency at wave &lt;jats:italic toggle=\"yes\"&gt;t&lt;/jats:italic&gt; + 1 (nonfrequent [≤once daily] vs frequent [several times daily]). Main Outcomes and Measures Past-year internalizing problems (nonelevated [≤3 symptoms] vs elevated [4 symptoms]) at wave &lt;jats:italic toggle=\"yes\"&gt;t&lt;/jats:italic&gt; + 2 via the Global Appraisal of Individual Needs–Short Screener (depression, anxiety, psychological distress, sleep difficulties). Results A total of 3788 person-interval observations (2561 [64.7%] female; aged 18-24 years at baseline) were included. Approximately 14% (n = 540) transitioned to nonfrequent use at &lt;jats:italic toggle=\"yes\"&gt;t&lt;/jats:italic&gt; + 1. Reduced use was associated with greater likelihood of nonelevated internalizing symptoms at &lt;jats:italic toggle=\"yes\"&gt;t&lt;/jats:italic&gt; + 2 (0.57 vs 0.49; prevalence difference, 0.07; 95% CI, 0.02-0.13; prevalence ratio, 1.15; 95% CI, 1.04-1.27). Findings were generally consistent across sensitivity analyses, including alternative exposure definitions (weekly or less vs several times daily social media use: prevalence ratio, 1.17; 95% CI, 1.04-1.33), alternative missing-data handling approaches (prevalence ratio, 1.14; 95% CI, 1.04-1.25), design-based analyses (prevalence ratio, 1.16; 95% CI, 1.06-1.28), concurrent models (prevalence ratio, 1.13; 95% CI, 1.01-1.26), and alternative outcome definitions using internalizing symptom counts, with non-frequent use associated with fewer symptoms (adjusted incidence rate ratio, 0.90; 95% CI, 0.85-0.96). Conclusions and Relevance In this cohort study, reduced social media use was associated with subsequent improvement in internalizing symptoms among US young adults with elevated symptoms and frequent use. These findings identify reduced social media use as a potentially mod","PeriodicalId":14683,"journal":{"name":"JAMA Pediatrics","volume":"4 1","pages":""},"PeriodicalIF":26.1,"publicationDate":"2026-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149415325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Attention-Deficit/Hyperactivity Disorder Accommodations, Behavior Therapy, and Stimulant Medication 注意缺陷/多动障碍适应,行为治疗和兴奋剂药物
IF 26.1 1区 医学
JAMA Pediatrics Pub Date : 2026-11-13 DOI: 10.1001/jamapediatrics.2026.5973
Gregory A. Fabiano, Brittany M. Merrill, Rosalia F. Gallo, Marcela Ramos, Morgan Jusko, Devon Tower, Elizabeth M. Gnagy, Amy Boeckel, Jennifer Piscitello, Maya Renaud, Alyssa Dawson, Jennifer Sikov, Carolina Ramirez, Grant C. Edmondson, Michael S. Adragna, Carlos A. Salgado, Timothy B. Hayes
{"title":"Attention-Deficit/Hyperactivity Disorder Accommodations, Behavior Therapy, and Stimulant Medication","authors":"Gregory A. Fabiano, Brittany M. Merrill, Rosalia F. Gallo, Marcela Ramos, Morgan Jusko, Devon Tower, Elizabeth M. Gnagy, Amy Boeckel, Jennifer Piscitello, Maya Renaud, Alyssa Dawson, Jennifer Sikov, Carolina Ramirez, Grant C. Edmondson, Michael S. Adragna, Carlos A. Salgado, Timothy B. Hayes","doi":"10.1001/jamapediatrics.2026.5973","DOIUrl":"https://doi.org/10.1001/jamapediatrics.2026.5973","url":null,"abstract":"Importance Although widely deployed, little is known about the efficacy of academic accommodations for attention-deficit/hyperactivity disorder (ADHD), alone or in combination of behavior therapy and stimulant medication. Objective To evaluate the efficacy of academic accommodations alone and in combination with behavioral interventions and stimulant medication. Design, Setting, and Participants This was a crossover randomized clinical trial with participants introduced to all conditions. Children with ADHD were enrolled in kindergarten through sixth grade. Academic accommodations were changed daily in a randomized order. Stimulant medication and placebo alternated weekly. The general classroom and enhanced behavior classroom intervention alternated every 2 weeks. The study was conducted in summer treatment program classrooms. For the present study, behavior was evaluated in (1) a classroom period where participants completed independent assignments and (2) a classroom period where participants were taught a lesson, completed small group cooperative tasks related to the lesson, and then took a quiz. Study data were analyzed from March to July 2026. Interventions The single and combined effects of academic accommodations, behavior therapy, and stimulant medication (methylphenidate, 0.3 mg/kg) were evaluated. Academic accommodations were extended time on tasks, frequent breaks during tasks, a low-distraction workspace, and the ability to stand at the desk, compared with a condition without an accommodation. A general classroom setting was compared with a classroom setting with enhanced behavior intervention. Main Outcomes and Measures Main outcomes were classroom rule violations during each of the two, 1-hour class periods, the number of seatwork items completed correctly (ie, academic productivity), and the quiz score. Results Of 306 children screened, 280 were enrolled in the study. A total of 255 children (mean [SD] age, 8.8 [1.6] months; 201 male [79%]) started the intervention, and 235 (84%) completed the study. Compared with placebo, stimulant medication increased effects related to seatwork productivity by 22% (ie, the rate ratio [RR] for this condition indicated that receiving medication compared with placebo multiplied the expected count of problems completed per minute by 1.22; 95% CI, 1.19-1.25), and quiz scores were significantly improved by 3.9 points (95% CI, 3.10-4.70 points). Medication and behavioral therapy significantly reduced classroom rule-breaking behavior by 37% (RR, 0.63; 95% CI, 0.60-0.67) and 61% (RR, 0.39; 95% CI, 0.37-0.42), respectively. There was no evidence that any of the academic accommodations significantly improved behavior or academic outcomes. No interactions were significant. Conclusions and Relevance Results of this crossover randomized clinical trial question whether school-based academic accommodations for children with ADHD should continue to be emphasized as accommodations were ineffective when used alone","PeriodicalId":14683,"journal":{"name":"JAMA Pediatrics","volume":"37 1","pages":""},"PeriodicalIF":26.1,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149396981","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is There a Case for Universal Newborn Screening for G6PD Deficiency?-Reply. 是否有必要对新生儿进行G6PD缺陷筛查?
IF 17.1 1区 医学
JAMA Pediatrics Pub Date : 2026-11-09 DOI: 10.1001/jamapediatrics.2026.5229
Elizabeth R Wolf, Colin J Orr, Alex R Kemper
{"title":"Is There a Case for Universal Newborn Screening for G6PD Deficiency?-Reply.","authors":"Elizabeth R Wolf, Colin J Orr, Alex R Kemper","doi":"10.1001/jamapediatrics.2026.5229","DOIUrl":"https://doi.org/10.1001/jamapediatrics.2026.5229","url":null,"abstract":"","PeriodicalId":14683,"journal":{"name":"JAMA Pediatrics","volume":" ","pages":""},"PeriodicalIF":17.1,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149378904","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Youth Exposure to Food and Beverage Marketing on Digital Media Platforms 青少年接触数字媒体平台上的食品和饮料营销
IF 26.1 1区 医学
JAMA Pediatrics Pub Date : 2026-11-09 DOI: 10.1001/jamapediatrics.2026.5190
Lisa M. Powell, Samantha Marinello, Julien Leider, Rebecca M. Schermbeck, Isabel McGoldrick, Devoja Ganguli, Andrea A. Pipito, Laura Vergeer, Monique Potvin Kent
{"title":"Youth Exposure to Food and Beverage Marketing on Digital Media Platforms","authors":"Lisa M. Powell, Samantha Marinello, Julien Leider, Rebecca M. Schermbeck, Isabel McGoldrick, Devoja Ganguli, Andrea A. Pipito, Laura Vergeer, Monique Potvin Kent","doi":"10.1001/jamapediatrics.2026.5190","DOIUrl":"https://doi.org/10.1001/jamapediatrics.2026.5190","url":null,"abstract":"Importance Youth are heavy users of digital devices, and digital media increasingly represents a source for unhealthy food marketing, which the World Health Organization highlights as a risk for poor diet and health. Objective To examine the extent and nature of youth exposure to food marketing on digital media across multiple platforms. Design, Setting, and Participants This cross-sectional study conducted from November 2024 to October 2025 used real-time screen capture data and surveyed screen use to estimate youth exposure to food marketing on digital media, including differences by sociodemographic characteristics. Content and nutritional analyses assessed marketed food categories, companies, and product healthfulness based on the Pan American Health Organization’s nutrient profile model (PAHO-NPM), as well as characteristics of marketing exposure. Participants included youth in the US aged 8 to 17 years. Exposure Food marketing on digital media. Main Outcomes and Measures Hours of smartphone and/or tablet device use per day and estimated median food marketing exposures per year among youth. Distribution of marketed food items by food category and company were analyzed, as was the percent exceeding the PAHO-NPM standard. Marketing exposures were reviewed by platform, source, and type. Results Participants included 1011 youth (median [IQR] age, 12 [10-15] years; 519 female [51.3%]; 511 aged 8-12 years; 500 aged 13-17 years). Participants reported spending a mean (SD) of 3.7 (1.9) hours per day using smartphones or tablets outside of school or homework activities. Estimated median number of food marketing exposures among youths was 3883 (IQR, 0-16 697) per year. Exposure was higher for adolescents vs children (10 107 [IQR, 0-26 205] per year vs 1427 [IQR, 0-7795] per year; &lt;jats:italic toggle=\"yes\"&gt;P&lt;/jats:italic&gt; &amp;amp;lt; .001), female vs male youths (8017 [IQR, 0-25 999] per year vs 2139 [0-9027] per year; &lt;jats:italic toggle=\"yes\"&gt;P&lt;/jats:italic&gt; &amp;amp;lt; .001), and youth with non–college-educated vs college-educated parents or guardians (5380 [IQR, 0-22 422] per year vs 3431 [IQR, 0-15 128] per year; &lt;jats:italic toggle=\"yes\"&gt;P&lt;/jats:italic&gt; = .04). Exposure was higher but not significant for non-Hispanic Black vs White youth (6358 [IQR, 0-24 053] vs 3697 [IQR, 0-16 287]; &lt;jats:italic toggle=\"yes\"&gt;P&lt;/jats:italic&gt; = .06). The largest food marketed categories were fast food (1983 of 6896 [28.8%]), sweets (1407 [20.4%]), and beverages (1384 [20.1%]). A total of 2437 of 2660 nonrestaurant food marketed items (91.6%) did not meet PAHO-NPM standards. A total of 4256 of 5154 food marketing exposures (82.6%) to youth were viewed on social media platforms (TikTok, 1565 of 5154 [30.4%] and YouTube, 1162 of 5154 [22.6%]). The majority of marketing exposures were paid (2703 of 5154 [52.4%]), 2261 (43.9%) were earned, and 190 (3.7%) were owned. Almost half (3231 of 6896 [46.9%]) of marketed food items were from Children’s Food and Beverage Adver","PeriodicalId":14683,"journal":{"name":"JAMA Pediatrics","volume":"57 1","pages":""},"PeriodicalIF":26.1,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149374822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Errors in Patient and Guardian Contact Information in Pediatric Electronic Health Record Systems 儿童电子健康记录系统中患者和监护人联系信息的错误
IF 26.1 1区 医学
JAMA Pediatrics Pub Date : 2026-11-09 DOI: 10.1001/jamapediatrics.2026.5337
Naveed Rabbani, Nymisha Chilukuri, Jonathan Hatoun, Tova Ronis, Laura Pike, Eleanor Verhagen, Carlin Barmada, Louis Vernacchio, Jessica Herstek, Natalie M. Pageler
{"title":"Errors in Patient and Guardian Contact Information in Pediatric Electronic Health Record Systems","authors":"Naveed Rabbani, Nymisha Chilukuri, Jonathan Hatoun, Tova Ronis, Laura Pike, Eleanor Verhagen, Carlin Barmada, Louis Vernacchio, Jessica Herstek, Natalie M. Pageler","doi":"10.1001/jamapediatrics.2026.5337","DOIUrl":"https://doi.org/10.1001/jamapediatrics.2026.5337","url":null,"abstract":"This cross-sectional study examines errors in patient and guardian contact information in the electronic health record (EHR) to measure the scope of inaccurate documentation and to substantiate the need for improved EHR standards and workflows.","PeriodicalId":14683,"journal":{"name":"JAMA Pediatrics","volume":"18 1","pages":""},"PeriodicalIF":26.1,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149374881","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is There a Case for Universal Newborn Screening for G6PD Deficiency? 是否有必要对新生儿进行G6PD缺陷筛查?
IF 17.1 1区 医学
JAMA Pediatrics Pub Date : 2026-11-09 DOI: 10.1001/jamapediatrics.2026.5232
Ramesh Vidavalur
{"title":"Is There a Case for Universal Newborn Screening for G6PD Deficiency?","authors":"Ramesh Vidavalur","doi":"10.1001/jamapediatrics.2026.5232","DOIUrl":"https://doi.org/10.1001/jamapediatrics.2026.5232","url":null,"abstract":"","PeriodicalId":14683,"journal":{"name":"JAMA Pediatrics","volume":" ","pages":""},"PeriodicalIF":17.1,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149378903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Air Pollution and Atopic Dermatitis in Children 空气污染与儿童特应性皮炎
IF 26.1 1区 医学
JAMA Pediatrics Pub Date : 2026-11-09 DOI: 10.1001/jamapediatrics.2026.5020
Megan Park, Samiha T. Mohsen, Emma Price, Sana Gupta, Jenna Mistry, Rachel Creighton, Michele Ramien, Bram Rochwerg, Aaron M. Drucker
{"title":"Air Pollution and Atopic Dermatitis in Children","authors":"Megan Park, Samiha T. Mohsen, Emma Price, Sana Gupta, Jenna Mistry, Rachel Creighton, Michele Ramien, Bram Rochwerg, Aaron M. Drucker","doi":"10.1001/jamapediatrics.2026.5020","DOIUrl":"https://doi.org/10.1001/jamapediatrics.2026.5020","url":null,"abstract":"Importance Atopic dermatitis is a common inflammatory skin condition that is heavily influenced by environmental factors, and while ambient air pollution has been linked to atopic dermatitis outcomes in adults, its effects in children remain more uncertain. Objective To synthesize the evidence examining the associations between ambient air pollutants and atopic dermatitis prevalence in children. Data Sources MEDLINE, Embase, and Cochrane databases were searched from inception to February 10, 2026. Study Selection Observational studies of children under 18 years of age that examined the association between at least 1 atopic dermatitis outcome of interest and a pollutant exposure were included. Data Extraction and Synthesis The PRISMA 2020 reporting guidelines were used; methodological quality was assessed using the Joanna Briggs Institute checklist, and risk of bias was evaluated using the risk of bias in nonrandomized studies of exposure effects (ROBINS-E) tool. Data were synthesized using random-effects models, and certainty of evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework. Main Outcomes and Measures The primary outcomes were health care utilization and prevalence, incidence, or severity of atopic dermatitis in relation to predefined ambient air pollutant exposures, including nitrogen dioxide (NO <jats:sub>2</jats:sub> ), sulfur dioxide (SO <jats:sub>2</jats:sub> ), particulate matter with a diameter of 10 µm or less (PM <jats:sub>10</jats:sub> ), particulate matter with a diameter of 2.5 µm or less (PM <jats:sub>2.5</jats:sub> ), ozone (O <jats:sub>3</jats:sub> ), carbon monoxide (CO), and traffic-related pollution. Results Of 2528 citations, 52 observational studies met the inclusion criteria and were included. It was found that every 10-µg/m <jats:sup>3</jats:sup> increase in NO <jats:sub>2</jats:sub> (odds ratio [OR], 3.46; 95% CI, 1.06-11.31; moderate certainty) and SO <jats:sub>2</jats:sub> (OR, 3.96; 95% CI, 1.00-15.65; moderate certainty) was probably associated with increased atopic dermatitis outpatient visits. It was also found that every 10-µg/m <jats:sup>3</jats:sup> increase in PM <jats:sub>2.5</jats:sub> (OR, 1.04; 95% CI, 1.00-1.08; moderate certainty) and PM <jats:sub>10</jats:sub> (OR, 1.19; 95% CI, 1.06-1.35; moderate certainty) was probably associated with higher atopic dermatitis prevalence. Findings were mixed or did not support associations between air pollutions exposure and incidence or severity of atopic dermatitis. Conclusions and Relevance This systematic review and meta-analysis found that increased levels of certain ambient air pollutants were probably associated with some increased population burden of atopic dermatitis in children.","PeriodicalId":14683,"journal":{"name":"JAMA Pediatrics","volume":"7 1","pages":""},"PeriodicalIF":26.1,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149374820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Satisfaction, Regret, and Harm After Hormone Therapy in Youth From a Multidisciplinary Gender Clinic 青少年荷尔蒙治疗后的满意度、后悔与伤害:来自多学科性别诊所
IF 26.1 1区 医学
JAMA Pediatrics Pub Date : 2026-11-09 DOI: 10.1001/jamapediatrics.2026.5185
Laura Kuper, Megan Ungerman, Bree Horrocks, Diane Chen, Ximena Lopez
{"title":"Satisfaction, Regret, and Harm After Hormone Therapy in Youth From a Multidisciplinary Gender Clinic","authors":"Laura Kuper, Megan Ungerman, Bree Horrocks, Diane Chen, Ximena Lopez","doi":"10.1001/jamapediatrics.2026.5185","DOIUrl":"https://doi.org/10.1001/jamapediatrics.2026.5185","url":null,"abstract":"Importance Concerns about regret and harm have led to restrictions on transgender and gender-diverse youths’ access to testosterone or estrogen therapy (ie, hormone therapy [HT]), while empirical data on decisional regret among those initiating HT as youth remain limited. Objectives To examine satisfaction, regret, and perceived harm among individuals who initiated HT as youth and to identify demographic and clinical characteristics associated with regret or harm and current HT status (receiving vs not). Design, Setting, and Participants This cohort study evaluates self-report surveys collected from October 2023 to October 2025 among former patients who initiated HT as youth at a single multidisciplinary gender clinic in the US. Data analysis was conducted from December 2025 to August 2026. Exposure Initiation of estrogen or testosterone. Main Outcomes and Measures Decision Regret Scale (DRS) total score (range, 0-100; higher scores indicate greater regret); item-level satisfaction, regret, and perceived harm; and current HT status. Associations with demographic and clinical characteristics were examined using nonparametric, Welch &lt;jats:italic toggle=\"yes\"&gt;t&lt;/jats:italic&gt; , Fisher exact, or Pearson χ &lt;jats:sup&gt;2&lt;/jats:sup&gt; tests as appropriate, with parametric sensitivity analyses for the DRS total score. Results Of the 376 participants who initiated HT as youth (112 [29.8%] initiating estrogen and 264 [70.2%] initiating testosterone; current age, 14-28 years; mean [SD] age, 20.9 [2.9] years; time since HT initiation: range, 1.2 months to 10.7 years; mean [SD], 4.9 [2.5] years), 4 were missing DRS scores, all of whom were currently receiving HT. Among the 372 respondents with DRS scores, overall decisional regret was very low (mean [SD] DRS score, 4.3 [14.7]; median [IQR], 0 [0-0]); 360 participants (96.8%) endorsed that receiving HT was the right decision, 10 (2.7%) reported regret, and 7 (1.9%) reported perceived harm. DRS scores were higher among participants not currently receiving HT vs currently receiving HT and among those identifying on the nonbinary vs binary spectrum; parametric sensitivity analyses estimated mean differences of 15.95 points (95% CI, 8.50-23.39) and 6.07 points (95% CI, 2.15-9.99), respectively. Participants not currently receiving HT (65 participants [17.3%]) were more likely than those currently receiving HT (311 [82.7%]) to have received testosterone (odds ratio, 3.58; 95% CI, 1.65-7.78; &lt;jats:italic toggle=\"yes\"&gt;P&lt;/jats:italic&gt; = .001) and identify on the nonbinary spectrum (odds ratio, 8.88; 95% CI, 4.76-16.58; &lt;jats:italic toggle=\"yes\"&gt;P&lt;/jats:italic&gt; &amp;amp;lt; .001), were older (mean difference, 1.04 years; 95% CI, 0.45-1.64 years; &lt;jats:italic toggle=\"yes\"&gt;P&lt;/jats:italic&gt; = .001), and had longer time since initiating HT (mean difference, 1.00 year; 95% CI, 0.48-1.53 years; &lt;jats:italic toggle=\"yes\"&gt;P&lt;/jats:italic&gt; &amp;amp;lt; .001). Neither regret or harm nor current HT status was associated with age at HT i","PeriodicalId":14683,"journal":{"name":"JAMA Pediatrics","volume":"64 1","pages":""},"PeriodicalIF":26.1,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149374821","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书